Abstract |
We followed 205 of 232 patients with medically intractable cervical dystonia for at least 3 months and up to 4 years, during which time they received 1,074 injections in 505 visits. One hundred forty-five of the 205 patients (71%) improved substantially (global rating greater than or equal to 2; from 0 = no response to 4 = marked improvement in severity and function) after 1 or more visits. Of the 89 patients who reported pain, 68 (76%) had almost complete relief of their pain. While most patients noted improvement within the 1st week after injection, some had a latency of up to 8.5 weeks. Duration of maximum benefit lasted up to 12.5 months in some, but the average was 11.2 weeks. Only 58 of 205 (28%) patients, seen in 76 of 505 visits (15% of all visits), had complications, primarily mild dysphagia (35 patients) or neck weakness (17 patients). We conclude that botulinum toxin is a safe and effective therapy for most patients with cervical dystonia.
|
Authors | J Jankovic, K Schwartz |
Journal | Neurology
(Neurology)
Vol. 40
Issue 2
Pg. 277-80
(Feb 1990)
ISSN: 0028-3878 [Print] United States |
PMID | 2300249
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Aged
- Botulinum Toxins
(administration & dosage, adverse effects, therapeutic use)
- Dose-Response Relationship, Drug
- Dystonia
(drug therapy)
- Female
- Humans
- Injections, Intramuscular
- Male
- Middle Aged
- Muscles
(physiopathology)
- Neck Muscles
(physiopathology)
|